At this year's Asia Biotech Expo, Taiwan's Glac Biotech, the only company in the country recognized with an FDA GRAS probiotic strain, will be showcasing its high-standard international probiotic manufacturing technologies, "PRONEX®" and "PRIMETEK®". Through an innovative technology seminar, they will present their research achievements in brain probiotic ingredients. Additionally, Glac Biotech has prepared special promotional activities for the expo. Customers who purchase or discuss cooperation during the event will enjoy exclusive offers from Glac Biotech. This gesture is not only a token of gratitude to the participants but also a sincere effort by Glac Biotech to promote the development of the probiotic market. (Glac Biotech booth: Nangang Exhibition Center Hall 1 J216)

At the expo, Glac Biotech will showcase its innovative research results on brain probiotic ingredients. This research aims to explore the effects of probiotics on brain health. Their functional compound strains include four excellent B strains (Bifidobacterium subsp. infantis BLI-02, Bifidobacterium breve Bv-889, Bifidobacterium subsp. lactis CP-9, Bifidobacterium bifidum VDD088) and an L strain (Lactobacillus plantarum PL-02) selected from the intestines of Olympic athletes, which balance the gut microbiota to promote brain health. This innovative research not only opens new avenues for probiotic applications but also provides significant references for global brain health research.

Leveraging its advanced patented manufacturing processes, "PRONEX® Probiotic Manufacturing Technology" and "PRIMETEK® Professional Probiotic ODM Integration Technology Service," Glac Biotech has created the optimal growth environment for probiotics. PRONEX® technology, through an automated remote control platform, eliminates human factors and uses patented exclusive encapsulation technology and a smart rapid cooling technology developed jointly with international companies to effectively protect the fresh activity of probiotics during production, ensuring they exert their maximum efficacy.

The PRIMETEK® Professional Probiotic ODM Integration Technology Service is a one-stop custom probiotic service for ODM clients, providing services from raw material research and development, production, custom probiotic formulations to end product manufacturing. The technical plant not only complies with international authoritative certification standards but is also equipped with professional quality control and assurance personnel, using scientific data for repeated verification to create champion probiotic products for golden clients. The combination of these two technologies gives Glac Biotech's probiotic ingredients and ODM capabilities a highly competitive edge in the market.

Glac Biotech states that the Taiwanese probiotic market has grown rapidly in recent years, becoming one of the important markets in the Asia-Pacific region. According to market data, the global probiotic market was valued at $88 billion in 2023 and is expected to reach $134.88 billion by 2031, with a compound annual growth rate (CAGR) of 6.29% from 2024 to 2031. This continuous rise in data demonstrates the vigorous development of probiotics in the global market, significantly driving the expansion of the health food market and increasing the competitiveness of the Taiwanese probiotic market.

Probiotics have been widely used to promote gut health, regulate immunity, and bring positive health impacts. With its superior research and development capabilities and innovative technology, Glac Biotech continuously invests in research and development, driving breakthroughs and applications in probiotic technology, securing a significant place in the global probiotic industry, and bringing more innovative champion probiotic products to global golden clients!